Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: A placebo controlled study

Clinical Endocrinology

Volumn 46, Issue 1, 1997, Pages 55-61

  Gonnelli, Stefano ^a   Cepollaro, Chiara ^a   Montomoli, Marcello ^a   Gennari, Luigi ^b   Montagnani, Andrea ^a   Palmieri, Rossella ^a   Gennari, Carlo ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; HUMAN GROWTH HORMONE; HYDROXYPROLINE; OSTEOCALCIN; PHOSPHATE; PLACEBO; SALCATONIN; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031014457     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.d01-1750.x     Document Type: Article

References (39)

1. Aloia, J.F., Zanzi, I., Ellis, K. & Jowsey, J. (1976) Effects of growth hormone in osteoporosis. Journal of Clinical Endocrinology and Metabolism, 43, 992-999.
2. Aloia, J.F., Vaswani, A., Kapoor, A., Yeh, J.K. & Cohn, S.H. (1985) Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism, 34, 124-129.
3. Aloia, J.F., Vaswani, A., Meunier, P.J., Edouard, C.M., Arlot, M.E., Yeh, J.K. & Cohn, S.H. (1987) Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin. Calcified Tissue International, 40, 253-259.
4. Bengtsson, B.A., Eden, S., Lonn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tolli, J., Sjostrom, L. & Isaksson, O.G.P. (1993) Treatment of adults with growth hormone (GH) deficiency with rceombinant human GH. Journal of Clinical Endocrinology and Metabolism, 76, 309-317.
5. Binnerts, A., Swart, G.R., Wilson, J.H.P., Hoogerbrugge, N., Pols, H.A.P., Birkenhager, J.C. & Lamberts, S.W,J. (1992) The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clinical Endocrinology, 37, 79-87.
6. Brixen, K., Nielsen, H.K., Mosekilde, L. & Flyvbjerg, A. (1990) A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. Journal of Bone and Mineral Research, 6, 609-618.
7. Civitelli, R., Gonnelli, S., Zacchei, F., Bigazzi, S., Vattimo, A., Avioli, L.V. & Gennari, C. (1988) Bone turnover in postmenopausal osteoporosis: effect of calcitonin treatment. Journal of Clinical Investigation, 82, 1268-1274.
8. Clemmesen, B., Overgaard, K., Riis, B., & Christiansen, C. (1993) Human growth hormone and growth hormone releasing hormone: a double-masked, placebo-controlled study of their effects on bone metabolism in elderly women. Osteoporosis International, 3, 330-336.
9. Collin, P., Nefussi, J.R., Wetterwald, A., Nicolas, V., Boy-Lefevre, M.L., Fleisch, H. & Forest, N. (1992) Expression of collagen, osteocalcin, and bone alkaline phosphatase in a mineralizing rat osteoblastic cell culture. Calcified Tissue International, 50, 175-183.
10. Degerblad, M., Elgindy, N., Hall, K., Sjoberg, H.E. & Thorén, M. (1992) Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinologica, 126, 387-393.
11. Erdtsieck, R.J., Pols, H.A.P., Valk, N.K., Van Ouwerkerk, B.M., Lamberts, S.W.J., Mulder, P. & Birkenhager, J.C. (1995) Treatment of postmenopausal osteoporosis with a combination of growth hormone and pamidronate: a placebo controlled trial. Clinical Endocrinology, 43, 557-565.
12. Frost, H.M. (1981) Coherence treatment of osteoporoses. Orthopedics Clinics of North America, 12, 649-669.
13. Gibbs, C.J., Jr, Joy, A., Heffner, R., Franko, M., Miyazarki, M.,. Asher, D., Parisi, J., Brown, P.W. & Gajdusek, D.C. (1985) Clinical and pathological features and laboratory confirmation of Creutzfeld-Jakob disease in a recipient of pituitary-derived human growth hormone. New England Journal of Medicine, 313, 734-738.
14. Holloway, L., Butterfield, G., Hintz, R.L., Gesundheit, N. & Marcus, R. (1994) Effects of recombinant human growth hormone on metabolic indices, body composition and bone turnover in healthy elderly women. Journal of Clinical Endocrinology and Metabolism, 79, 470-479.
15. Holmes, S.J., Economou, G., Whitehouse, R.W., Adams, J.E. & Shalet, S.M. (1994) Reduced bone mineral density in patients with adult onset growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 78, 669-674.
16. Holmes, S.J., Whitehouse, R.W., Swindell, R., Economou, G., Adams, J.E. & Shalet, S.M. (1995) Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Clinical Endocrinology, 42, 627-633.
17. Inzucchi, S.E. & Robbins, R.J. (1994) Effects of growth hormone on human bone biology. Journal of Clinical Endocrinology and Metabolism, 79, 691-694.
18. Johansen, J.S., Pedersen, S.A., Jørgensen, J.O.L., Riis, B.J., Christiansen, C., Christiansen, J.S. & Skakkebaek, N.E. (1990) Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 70, 916-919.
19. Kassem, M., Blum, W., Risteli, J., Mosekilde, L. & Eriksen, E.F. (1993) Growth hormone stimulates proliferation and differentiation of human osteoblast-like cells in vitro. Calcified Tissue International, 52, 222-226.
20. Kassem, M., Brixen, K., Blum, W.F., Mosekilde, L. & Eriksen, E.F. (1994) Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis. Journal of Bone and Mineral Research, 9, 1365-1370.
21. Kaufman, J.M., Taelman, P., Vermeulen, A. & Vandeweghe, M. (1992) Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. Journal of Clinical Endocrinology and Metabolism, 74, 118-123.
22. Lieberman, S.A., Holloway, E., Marcus, R. & Hoffman, A.R. (1987) Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium and calcitriol metabolism and bone remodeling in postmenopausal women. Journal of Rone and Mineral Research, 9, 1723-1728.
23. Lindsay, R. & Thome, G.F. (1990) Estrogen treatment of patients with established postmenopausal osteoporosis. Obstetrics and Gynecology, 76, 290-295.
24. Marcus, R., Butterfield, G., Holloway, L., Gilliland, L., Baylink, D.J., Hintz, R.L. & Sherman, B.M. (1990) Effects of short term administration of recombinant human growth hormone to elderly people. Journal of Clinical Endocrinology and Metabolism, 70, 519-527.
25. O'Halloran, D.J., Tsatsoulis, A., Whitehouse, R.W., Holmes, S.J., Adams, J.E. & Shalet, S.M. (1993) Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. Journal of Clinical Endocrinology and Metabolism, 76, 1344-1348.
26. Parfitt, A.M. (1980) Morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis. Mineral Electrolyte Metabolism, 4, 273-287.
27. Parfitt, A.M. (1988) Relationship to the amount and structure of bone and the pathogenesis and prevention of fractures. In Osteoporosis: Etiology, Diagnosis and Management (eds B. L. Riggs & L. J. Melton III), pp. 45-93. Raven Press, New York.
28. Parfitt, A.M. (1991) Growth hormone and adult bone remodelling. Clinical Endocrinology, 35, 467-470.
29. Prockop, D.J. & Udenfriend, S. (1960) A specific method for the analysis of hydroxyproline in tissues and urine. Analytical Biochemistry, 1, 228-239.
30. Reeve, J., Meunier, P., Parsons, J.A., Bernat, M., Bijovet, O.L., Courpron, P., Edouard, C., Klenerman, L., Neer, R.M., Renier, J.C., Slovik, D., Vismans, F.J. & Potts, J.T. (1980) Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutational osteoporosis: a multicentre trial. British Medical Journal, 280, 1340-1344.
31. Riggs, B.L., Hodgson, S.F., O'Fallon, W.M., Chao, E.Y.S., Wahner, H.W., Huhs, J.M., Cedel, S.L. & Melton, III L.J. (1990) Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. New England Journal of Medicine, 322, 802-809.
32. Rudman, D., Feller, A.G., Nagraj, H.S., Gergans, G.A., Lalitha, P.Y., Goldberg, A.F., Schlenker, R.A., Cohn, L., Rudman, I.W. & Mattson, D.E. (1990) Effects of human growth hormone in men over 60 years old. New England Journal of Medicine, 323, 1-6.
33. Rudman, D., Feller, A.G., Cohn, L., Shetty, K.R., Rudman, I.W. & Draper, M.W. (1991) Effects of human growth hormone on body composition in elderly men. Hormone Research, 36, 73-81.
34. Schlemmer, A., Johansen, J.S., Pedersen, S.A., Jørgensen, J.O.L., Hassager, C. & Christiansen, C. (1995) The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clinical Endocrinology, 34, 471-476.
35. Storm, T., Thamsborg, G., Steiniche, T., Genant, H.K. & Sorensen, O.H. (1990) Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. New England Journal of Medicine, 322, 1265-1271.
36. Valk, N.K., Erdtsieck, R.J., Algra, D., Lamberts, S.W.J. & Pols, H.A.P. (1995) Combined treatment of growth hormone and the bisphosphonate pamidronate, versus treatment with GH alone in GH-deficient adults: the effects of renal phsophate handling, bone turnover and bone mineral mass. Clinical Endocrinology, 43, 317-324.
37. Vandeweghe, M., Taelman, P. & Kaufman, J.M. (1993) Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clinical Endocrinology, 39, 409-415.
38. Whitehead, H.M., Boreham, C., McIlrath, E.M., Sheridan, B., Kennedy, L., Atkinson, A.B. & Hadden, D.R. (1992) Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clinical Endocrinology, 36, 45-52.
39. Zerbe, G.O. (1970) Randomization analysis of the completely randomized design extended to growth and response curves. Journal of the American Statistical Association, 74, 215-221.